ARE Patent Litigation Alert:
Federal Circuit Turns Its Attention to Natural Phenomena Under 35 U.S.C. § 101

On December 17, 2010, the U.S. Court of Appeals for the Federal Circuit issued an Opinion and Order confirming the patent-eligibility of claims directed to methods used in treating gastrointestinal and non-gastrointestinal autoimmune diseases in Prometheus Laboratories, Inc. v. Mayo Collaborative Services, No. 2008-1403 (Fed. Cir. Dec. 17, 2010). The district court in Prometheus granted […]

ARE Patent Litigation Alert: Federal Circuit Turns Its Attention to Natural Phenomena Under 35 U.S.C. § 101

On December 17, 2010, the U.S. Court of Appeals for the Federal Circuit issued an Opinion and Order confirming the patent-eligibility of claims directed to methods used in treating gastrointestinal and non-gastrointestinal autoimmune diseases in Prometheus Laboratories, Inc. v. Mayo Collaborative Services, No. 2008-1403 (Fed. Cir. Dec. 17, 2010). The district court in Prometheus granted […]